FDA, pharma and device came together for the first time in August of 2017 at the Xavier AI Summit to explore together how Artificial Intelligence can advance quality operations into the future...today. Xavier formed two working teams through the August Summit to explore solutions for industry-wide adoption of AI in quality operations. Learn firsthand what the excitement is all about as the working team leaders share their insights
Xavier University has launched the Center for Artificial Intelligence to help FDA and industry advance its predictive capabilities…and even move towards prescriptive capabilities. Rob Studt and Ryan Schoenfeld will share with you how Janssen (a J&J company) have built their own internal capabilities to identify patterns in clinical trial data and end points, and are moving into applications in quality operations. The use of artificial intelligence arms us with information and signals that lie within our data and documents, but typically goes undetected until a failure occurs. Move your organization from one that is reactive to one that is predictive. Then take that learning to prescribe your actions in order to set your organization up for success before you even start.